Nonclassical renin-angiotensin system and renal function.

Area of Science:

• Cardiovascular Physiology
• Renal Physiology
• Endocrinology

Background:

• The renin-angiotensin system (RAS) is crucial for blood pressure regulation.
• Dysregulation of RAS contributes to cardiovascular diseases and kidney injury.
• RAS blockade via ACE inhibitors or AT1R antagonists is a therapeutic strategy.

Purpose of the Study:

• To elucidate the distinct roles of the classical and non-classical RAS pathways.
• To highlight the therapeutic potential of non-classical RAS components in managing hypertension and renal injury.

Main Methods:

• Review of existing literature on RAS components and their functions.
• Analysis of the interplay between classical (ACE-Ang II-AT1R) and non-classical (ACE2-Ang-(1-7)-AT7R, AngII/Ang III-AT2R) axes.
• Examination of evidence supporting the renoprotective and antihypertensive effects of non-classical RAS modulation.

Main Results:

• The classical RAS (ACE-Ang II-AT1R) promotes vasoconstriction, sodium retention, and pathological effects like oxidative stress and fibrosis.
• The non-classical RAS, involving ACE2-Ang-(1-7)-AT7R and AngII/Ang III-AT2R, generally opposes classical RAS actions.
• Non-classical RAS mediates vasodilation, natriuresis, and reduces oxidative stress, contributing to normal renal function.

Conclusions:

• The non-classical RAS pathways counterbalance the detrimental effects of the classical RAS.
• Targeting non-classical RAS components offers a promising therapeutic approach for hypertension and renal protection.
• Understanding the dual roles of RAS is vital for developing effective cardiovascular and renal treatments.